BACKGROUND: Earlier, more accurate assessment of secondary brain injury is essential in management of patients with traumatic brain injury (TBI). We assessed the accuracy and utility of high-resolution automated intracranial pressure (ICP) and cerebral perfusion pressure (CPP) recording and their analysis in patients with severe TBI. METHODS: ICP and CPP data for 30 severe TBI patients were collected automatically at 6-second intervals. The degree and duration of ICP and CPP above and below treatment thresholds were calculated as "pressure times time dose" (PTD; mm Hg . h) using automated recordings (PTDa) or manual recordings (PTDm) for early stage (trauma resuscitation unit [TRU]) and total monitoring time (TRU and intensive care unit). RESULTS: Bland-Altman plots showed lack of agreement between PTDa and PTDm. For ICP >20 mm Hg and CPP <60 mm Hg, PTDa, but not PTDm, was significantly higher in patients with unfavorable outcome (Extended Glasgow Outcome Scale score <or=4) than in patients with favorable outcome (Extended Glasgow Outcome Scale score >4). Total PTDa for ICP >20 mm Hg and CPP <60 mm Hg had high predictive power for functional outcome (area under the receiver operating characteristics curve: 0.92 +/- 0.05 and 0.82 +/- 0.08, respectively) and inhospital mortality (0.76 +/- 0.15 and 0.79 +/- 0.14, respectively) and were strongly correlated with length of intensive care unit stay (p = 0.009 and 0.007), length of hospital stay (p = 0.009 and 0.005), and discharge Glasgow Coma Scale scores (p = 0.008 and p = 0.038). PTDa of CPP >100 mm Hg during TRU monitoring and during the first 24 hours showed highest predictive power for mortality (area under the receiver operating characteristics curve: 0.72 +/- 0.18 and 0.85 +/- 0.13, respectively). PTDa was better than PTDm and the duration of episodes alone in predicting outcome. CONCLUSIONS: PTD calculation of high resolution ICP and CPP recording is a reliable and feasible way of monitoring severe TBI patients.
BACKGROUND: Earlier, more accurate assessment of secondary brain injury is essential in management of patients with traumatic brain injury (TBI). We assessed the accuracy and utility of high-resolution automated intracranial pressure (ICP) and cerebral perfusion pressure (CPP) recording and their analysis in patients with severe TBI. METHODS: ICP and CPP data for 30 severe TBIpatients were collected automatically at 6-second intervals. The degree and duration of ICP and CPP above and below treatment thresholds were calculated as "pressure times time dose" (PTD; mm Hg . h) using automated recordings (PTDa) or manual recordings (PTDm) for early stage (trauma resuscitation unit [TRU]) and total monitoring time (TRU and intensive care unit). RESULTS: Bland-Altman plots showed lack of agreement between PTDa and PTDm. For ICP >20 mm Hg and CPP <60 mm Hg, PTDa, but not PTDm, was significantly higher in patients with unfavorable outcome (Extended Glasgow Outcome Scale score <or=4) than in patients with favorable outcome (Extended Glasgow Outcome Scale score >4). Total PTDa for ICP >20 mm Hg and CPP <60 mm Hg had high predictive power for functional outcome (area under the receiver operating characteristics curve: 0.92 +/- 0.05 and 0.82 +/- 0.08, respectively) and inhospital mortality (0.76 +/- 0.15 and 0.79 +/- 0.14, respectively) and were strongly correlated with length of intensive care unit stay (p = 0.009 and 0.007), length of hospital stay (p = 0.009 and 0.005), and discharge Glasgow Coma Scale scores (p = 0.008 and p = 0.038). PTDa of CPP >100 mm Hg during TRU monitoring and during the first 24 hours showed highest predictive power for mortality (area under the receiver operating characteristics curve: 0.72 +/- 0.18 and 0.85 +/- 0.13, respectively). PTDa was better than PTDm and the duration of episodes alone in predicting outcome. CONCLUSIONS:PTD calculation of high resolution ICP and CPP recording is a reliable and feasible way of monitoring severe TBIpatients.
Authors: Kevin N Sheth; Deborah M Stein; Bizhan Aarabi; Peter Hu; Joseph A Kufera; Thomas M Scalea; Daniel F Hanley Journal: Neurocrit Care Date: 2013-02 Impact factor: 3.210
Authors: Deborah M Stein; Megan Brenner; Peter F Hu; Shiming Yang; Erin C Hall; Lynn G Stansbury; Jay Menaker; Thomas M Scalea Journal: Neurocrit Care Date: 2013-06 Impact factor: 3.210
Authors: Timothy P Welch; Michael J Wallendorf; Evan D Kharasch; Jeffrey R Leonard; Allan Doctor; Jose A Pineda Journal: Crit Care Med Date: 2016-04 Impact factor: 7.598
Authors: Fabian Güiza; Bart Depreitere; Ian Piper; Giuseppe Citerio; Iain Chambers; Patricia A Jones; Tsz-Yan Milly Lo; Per Enblad; Pelle Nillson; Bart Feyen; Philippe Jorens; Andrew Maas; Martin U Schuhmann; Rob Donald; Laura Moss; Greet Van den Berghe; Geert Meyfroidt Journal: Intensive Care Med Date: 2015-04-18 Impact factor: 17.440
Authors: Michael J Souter; Patricia A Blissitt; Sandralee Blosser; Jordan Bonomo; David Greer; Draga Jichici; Dea Mahanes; Evie G Marcolini; Charles Miller; Kiranpal Sangha; Susan Yeager Journal: Neurocrit Care Date: 2015-08 Impact factor: 3.210